Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice
Authors:
- Hidetoshi NakamuraHNHidetoshi Nakamura
- Yoshiki ShiraishiYSYoshiki Shiraishi
- Momoyo FuruuchiMFMomoyo Furuuchi
- 1 May 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 294 (5) , L882-L890
Abstract
Besides lowering cholesterol, statins exert multiple effects, such as anti-inflammatory activity and improvement of endothelial cell function. We examined whether simvastatin (SS) protects against the development of elastase-induced pulmonary emphysema in mice by using mean linear intercepts of alveoli (Lm) as a morphometric parameter of emphysema. After injection of intratracheal elastase on day 0, C57BL/6 mice were treated daily with SS (SS+ group) or PBS (SS− group) for 2 wk. A 21% decrease in Lm on day 7 was observed in the SS+ group vs. the SS− group. Anti-inflammatory effects of SS were observed as a decrease in percentage of neutrophils up to day 3, and in hydroxyproline concentration on day 3, in bronchoalveolar lavage fluid (BALF). SS also increased the number of proliferating cell nuclear antigen (PCNA)-positive alveolar epithelial cells between days 3 and 14. To confirm the role of statins in promoting proliferation of alveolar cells, mice were treated with SS (SS+) vs. PBS (SS−) for 12 days, starting 3 wk after elastase administration. After SS treatment, Lm decreased by 52% and PCNA-positive alveolar epithelial cells increased compared with the SS− group. Concentrations of vascular endothelial growth factor in BALF and endothelial nitric oxide synthase protein expression in pulmonary vessels tended to be higher in the SS+ group vs. the SS− group in this protocol. In conclusion, SS inhibited the development of elastase-induced pulmonary emphysema in mice. This therapeutic effect was due not only to anti-inflammation but also to the promotion of alveolar epithelial cell regeneration, partly mediated by restoring endothelial cell functions.Keywords
This publication has 39 references indexed in Scilit:
- Increased expression of vascular endothelial growth factor in small hepatocellular carcinomaJournal of Viral Hepatitis, 2006
- High-Dose Atorvastatin Improves Hypercholesterolemic Coronary Endothelial Dysfunction Without Improving the Angiogenic ResponseCirculation, 2006
- Mobilizing Endothelial Progenitor CellsHypertension, 2005
- Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cellsBiochemical and Biophysical Research Communications, 2004
- Atorvastatin reduces proinflammatory markers in hypercholesterolemic patientsAtherosclerosis, 2004
- Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stabilityAtherosclerosis, 2004
- HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent “direct” effects on atherosclerotic vessels in high cholesterol diet-fed rabbitsPharmacological Research, 2003
- Statin effects beyond lipid lowering—are they clinically relevant?European Heart Journal, 2003
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001